Citations

Citations to this article as recorded by  

• Reduction-responsive and tumor-targeted polyprodrug nanocarriers for targeting therapy of hepatocellular carcinoma
  Wei Shi, Xiaoqing Xu, Jinyuan Tian, Ziyi Zhang, Zhanjun Liu
  New Journal of Chemistry.2024; 48(9): 3793.     CrossRef
• CD44: A New Prognostic Marker in Colorectal Cancer?
  Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo
  Cancers.2024; 16(8): 1569.     CrossRef
• The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells
  V. O. Novosad, D. V. Maltseva
  Bulletin of Experimental Biology and Medicine.2023; 175(1): 144.     CrossRef
• Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
  Sweta Suman, Subhransu Kumar Hota, Pranati Misra, Nageswar Sahu, Subrat Sahu
  Cureus.2023;[Epub]     CrossRef
• Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer
  Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani, Amirhossein Sahebkar
  Process Biochemistry.2022; 115: 19.     CrossRef
• The presentation and regulation of the IL-8 network in the epithelial cancer stem-like cell niche in patients with colorectal cancer
  Guanglin Cui, Gui Li, Zhigang Pang, Jon Florholmen, Rasmus Goll
  Biomedicine & Pharmacotherapy.2022; 152: 113252.     CrossRef
• Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
  Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee, Hamed Haddad Kashani
  Oncology and Therapy.2022; 10(2): 451.     CrossRef
• Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications
  Guanglin Cui, Ziqi Wang, Hanzhe Liu, Zhigang Pang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Evaluation and Clinicopathological Correlation of CD44 in Colorectal Adenoma with Low/High-Grade Dysplasia and Carcinoma
  Himanshi Bhanu, Ruchi Mittal, Sarojini Raman
  Clinical Cancer Investigation Journal.2022; 11(6): 9.     CrossRef
• The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan
  Yuan-Chang Dai, Chuan-Yin Fang, Hsin-Yi Yang, Yi-Jun Jian, Shou-Chieh Wang, Yi-Wen Liu, Frédéric André
  PLOS ONE.2021; 16(7): e0254000.     CrossRef
• Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers
  Melanie M. Ivancic, Bryant W. Megna, Yuriy Sverchkov, Mark Craven, Mark Reichelderfer, Perry J. Pickhardt, Michael R. Sussman, Gregory D. Kennedy
  Journal of Surgical Research.2020; 246: 160.     CrossRef
• Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases
  Jon Danel Solano-Iturri, Maider Beitia, Peio Errarte, Julio Calvete-Candenas, María C. Etxezarraga, Alberto Loizate, Enrique Echevarria, Iker Badiola, Gorka Larrinaga
  Aging.2020; 12(11): 10337.     CrossRef
• The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma
  Salem Y. Mohamed, Randa Mohamed Kaf, Mona Mostafa Ahmed, Amira Elwan, Hassan R Ashour, Amr Ibrahim
  Journal of Gastrointestinal Cancer.2019; 50(4): 824.     CrossRef
• Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
  Gui-Min Wen, Fei-Fei Mou, Wei Hou, Dan Wang, Pu Xia
  Stem Cell Reviews and Reports.2019; 15(1): 23.     CrossRef
• The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
  Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Modulation of CD44, EGFR and RAC Pathway Genes (WAVE Complex) in Epithelial Cancers
  Pranathi Tata, Piyush Gondaliya, Aditya Sunkaria, Akshay Srivastava, Kiran Kalia
  Current Pharmaceutical Design.2019; 25(8): 833.     CrossRef
• CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
  Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai, Yiping Lu
  Medicine.2018; 97(23): e10446.     CrossRef
• DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
  Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends
  PeerJ.2018; 6: e5530.     CrossRef
• CD133 and CD44 as cancer stem cell markers in bladder carcinoma
  Rania ES. Wasfy, Dina M. El-Guindy
  Egyptian Journal of Pathology.2017; 37(1): 204.     CrossRef
• Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance
  Ji Eun Choi, Jun Sang Bae, Myoung Jae Kang, Myoung Ja Chung, Kyu Yun Jang, Ho Sung Park, Woo Sung Moon
  Oncology Reports.2017; 38(3): 1695.     CrossRef
• Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells
  Natasha Hodgkinson, Cherie A Kruger, Heidi Abrahamse
  Tumor Biology.2017; 39(10): 101042831773469.     CrossRef
• Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis
  Zhan Yu, Zhen Chen, Jian Wu, Zhong Li, Yugang Wu, Surinder K. Batra
  PLOS ONE.2017; 12(11): e0188139.     CrossRef
• Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence
  Guanglin Cui, Gang Xu, Li Zhu, Zhigang Pang, Wei Zheng, Zhenfeng Li, Aping Yuan
  Oncotarget.2017; 8(28): 45311.     CrossRef
• A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
  Rabia Bilge Özgül Özdemir, Alper Tunga Özdemir, Fatih Oltulu, Kamile Kurt, Gürkan Yiğittürk, Cengiz Kırmaz
  Annals of Diagnostic Pathology.2016; 25: 60.     CrossRef
• Implications of OCT4 in breast carcinoma from initiation to lymph node metastasis
  Hoda H. Abou Gabal, Riham M. Abu-Zeid, Maissa N. El-Maraghy
  Egyptian Journal of Pathology.2016; 36(2): 194.     CrossRef
• CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
  Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang, Yuanjie Niu
  Oncotarget.2016; 7(9): 10023.     CrossRef
• Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
  Pu Xia, Xiao-Yan Xu
  Oncotarget.2016; 7(29): 45538.     CrossRef
• Clinical Implication of Colorectal Cancer Stem Cells: Still Has a Long Way to Go
  Hungdai Kim
  Annals of Coloproctology.2015; 31(3): 79.     CrossRef
• Advances and perspectives of colorectal cancer stem cell vaccine
  Mei Guo, Jun Dou
  Biomedicine & Pharmacotherapy.2015; 76: 107.     CrossRef